News › Clinical Practice, Industry News, Patient Care

Allergan Aesthetics Enters into Option to Acquire Cypris Medical

January 13, 2021

Allergan Aesthetics, an AbbVie company, has announced that it has entered into a warrant agreement with Cypris Medical, a privately held medical device company based in Chicago. Following the completion of a clinical trial to be initiated in 2021, Allergan Aesthetics will have the right to exercise an option to acquire Cypris Medical, including the company’s Xact device. The planned clinical trial will evaluate the safety and effectiveness of Xact in treating mid-face descent, as well as for neck lifts.
Replacing the scalpel, Xact is designed to allow for lifting and suturing of the superficial muscular aponeurotic system (SMAS), the same tissue mobilized in a facelift, but in a minimally-invasive manner. The innovative technology intends to provide patients surgery-like results in the office with little to no downtime.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • PracticeQ Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Fresh Clinics Acquires Spakinect
    • Arkansas Nursing Board Comment Deadline Approaching for Medical Aesthetics and IV Hydration Guidance
    • Acquisition Lets AI and Operators Learn From Nearly $2 Billion in Annual Aesthetics Transactions
    • Longevity, Safety, and Innovation: Merz Aesthetics on Natural Results and the Future of Regenerative Aesthetics
Advertisement